LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.

Fourth Quarter Fiscal 2026 Summary*: * Revenue was $42.4 million, a decrease of 23.1% from the prior year period; * Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%; * Net income per diluted share was $0.10, versus $0.15 per diluted share a year ago; * Adjusted earnings per diluted share was $0.11, compared to $0.17 a year ago; and * Adjusted EBITDA was $2.7 million compared to $4.8 million a year ago. (* All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2026 to the fourth quarter of fiscal 2025, unless otherwise noted.)